Johnson & Johnson (JNJ) Equity Ratio (2009 - 2026)

Johnson & Johnson has disclosed Equity Ratio across 18 years of filings, most recently posting 0.4 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.4, changed 0.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.4 (changed 0.2% YoY), and the FY2025 annual result was 0.41, up 3.12% from the prior year.
• Equity Ratio came in at 0.4 for Q1 2026 at Johnson & Johnson, down from 0.41 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.43 in Q3 2022 to a low of 0.36 in Q2 2023.
• The 5-year median for Equity Ratio is 0.41 (2022), against an average of 0.41.
• Across the five-year window, Equity Ratio retreated 13.67% in 2023 and grew 12.59% in 2024, its largest moves.
• Johnson & Johnson's Equity Ratio stood at 0.43 in 2022, then retreated by 3.65% to 0.41 in 2023, then decreased by 3.29% to 0.4 in 2024, then gained by 3.12% to 0.41 in 2025, then declined by 1.27% to 0.4 in 2026.
• The last three Equity Ratio figures came in at 0.4 (Q1 2026), 0.41 (Q4 2025), and 0.41 (Q3 2025), per Business Quant data.